Intrapartum beta-lactam antibiotics for preventing group B streptococcal early-onset disease: can we abandon the concept of ‘inadequate’ intrapartum antibiotic prophylaxis?

References

• Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B Streptococcal disease. Revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59:1–36.
   PubMedGoogle Scholar
• Edwards MS, Nizet V, Baker CJ. Group B Streptococcal infections. In: Remington and Klein’s. Infectious diseases of the fetus and newborn infant. 8th ed. Elsevier; 2016. p. 411–456.
   Google Scholar
• Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013;28:31–42.
   Web of Science ®Google Scholar
• Di Renzo GC, Melin P, Berardi A, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med. 2015;28(7):766–782.
   PubMed Web of Science ®Google Scholar
• Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103:e77.
   PubMed Web of Science ®Google Scholar
• Boyer KM, Gotoff SP. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother. 1985;35:267–280.
   PubMedGoogle Scholar
• Berardi A, Cattelani C, Creti R, et al. Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination. Expert Rev Anti Infect Ther. 2015;13:1387–1399.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal group B streptococcal colonization. Cochrane Database Syst Rev. 2014;6:CD007467.
   PubMed Web of Science ®Google Scholar
• Matorras R, García-Perea A, Omeñaca F, et al. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol. 1991;40:57–62.
   PubMed Web of Science ®Google Scholar
• Lim DV, Morales WJ, Walsh AF, et al. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol. 1986;23:489–492.
   PubMed Web of Science ®Google Scholar
• Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314:1665–1669.
   PubMed Web of Science ®Google Scholar
• Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol. 1989;73(4):583–587.
   PubMed Web of Science ®Google Scholar
• Garland SM, Fliegner JR. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol. 1991;31(2):119–122.
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342(1):15–20.
   PubMed Web of Science ®Google Scholar
• Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 2019;173(3):224–233.
   PubMed Web of Science ®Google Scholar
• Hughes RG, Brocklehurst P, Steer PJ, et al. Prevention of early-onset neonatal group B streptococcal disease. Green-top guideline no. 36. BJOG. 2017;124:e280–305.
   PubMed Web of Science ®Google Scholar
• Alós Cortés JI, Andreu Domingo A, Arribas Mir L, et al. Prevention of perinatal group B streptococcal disease. Updated Spanish recommendations 2012. Rev Esp Quimioter. 2012;25(1):79–88.
   PubMed Web of Science ®Google Scholar
• Darlow B, Campbell N, Austin N, et al. The prevention of early-onset neonatal group B streptococcus infection: new Zealand consensus guidelines 2014. N Z Med J. 2015;128(1425):69–76.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Prevention of group B streptococcal early-onset disease in newborns: ACOG committee opinion, number 782. Obstet Gynecol. 2019;134(1):e19–e40.
   PubMed Web of Science ®Google Scholar
• Money D, Allen VM. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can. 2018;40:e665–74.
   PubMed Web of Science ®Google Scholar
• Puopolo KM, Lynfield R, Cummings JJ. Management of infants at risk for group B streptococcal disease. Pediatrics. 2019;144(2):e20191881.
   PubMed Web of Science ®Google Scholar
• Lee B, Newland JG, Jhaveri R. Reductions in neonatal listeriosis: “Collateral benefit” of group B streptococcal prophylaxis? J Infect. 2016;72(3):317–323.
   PubMed Web of Science ®Google Scholar
• Schuchat A, Zywicki SS, Dinsmoor MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics. 2000;105(1):21–26.
   PubMed Web of Science ®Google Scholar
• Puopolo KM, Benitz WE, Zaoutis TE. Management of neonates born at ≥35 0/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142:e2018–894.
   Google Scholar
• Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138(6):e20162013.
   PubMed Web of Science ®Google Scholar
• Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed. 2011;96:F9–14.
   PubMed Web of Science ®Google Scholar
• Berardi A, Baroni L, Bacchi Reggiani ML, et al. GBS prevention working group Emilia-Romagna. The burden of early-onset sepsis in Emilia-Romagna (Italy): a 4-year, population-based study. J Matern Fetal Neonatal Med. 2016;29(19):3126–3131.
   PubMed Web of Science ®Google Scholar
• Berardi A, Fornaciari S, Rossi C, et al. Safety of physical examination alone for managing well-appearing neonates ≥ 35 weeks’ gestation at risk for early-onset sepsis. J Matern Fetal Neonatal Med. 2015;28:1123–1127.
   PubMed Web of Science ®Google Scholar
• van Herk W, Stocker M, van Rossum AM. Recognising early onset neonatal sepsis: an essential step in appropriate antimicrobial use. J Infect. 2016;72:S77–82.
   PubMed Web of Science ®Google Scholar
• Flidel-Rimon O, Galstyan S, Juster-Reicher A, et al. Limitations of the risk factor based approach in early neonatal sepsis evaluations. Acta Paediatr. 2012;101:e540.
   PubMed Web of Science ®Google Scholar
• Randis TM, Polin RA, Saade G. Chorioamnionitis: time for a new approach. Curr Opin Pediatr. 2017;29:159–164.
   PubMed Web of Science ®Google Scholar
• Hooven TA, Randis TM, Polin RA. What’s the harm? Risks and benefits of evolving rule-out sepsis practices. J Perinatol. 2018;(38):614–622.
   PubMed Web of Science ®Google Scholar
• Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123:58–66.
   PubMed Web of Science ®Google Scholar
• Kuppala VS, Meinzen-Derr J, Morrow AL, et al. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr. 2011;159:720–725.
   PubMed Web of Science ®Google Scholar
• Ficara M, Pietrella E, Spada C, et al. Changes of intestinal microbiota in early life. J Matern Fetal Neonatal Med. 2018:1–8  [Epub ahead of print].
   PubMedGoogle Scholar
• Berardi A, Rossi C, Spada C, et al. GBS prevention working group Emilia-Romagna. Strategies for preventing early-onset sepsis and for managing neonates at-risk: wide variability across six Western countries. J Matern Fetal Neonatal Med. 2019;32(18):3102–3108.
   PubMed Web of Science ®Google Scholar
• Schrag S, Gorwitz R, Fultz-Butts K, et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR–11):1–22.
   PubMedGoogle Scholar
• Creti R, Imperi M, Berardi A, et al. Neonatal group B streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 Years of surveillance. Pediatr Infect Dis J. 2017;36(3):256–262.
   PubMed Web of Science ®Google Scholar
• Idsoe O, Guthe T, Willcox RR, et al. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ. 1968;38(2):159–188.
   PubMed Web of Science ®Google Scholar
• Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med. 2001;345(11):804–809.
   PubMed Web of Science ®Google Scholar
• Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009;360(25):2626–2636.
   PubMed Web of Science ®Google Scholar
• Berardi A, Rossi C, Bacchi Reggiani ML, et al. An area-based study on intrapartum antibiotic prophylaxis for preventing group B streptococcus early-onset disease: advances and limitations. J Matern Fetal Neonatal Med. 2017;30:1739–1744.
   PubMed Web of Science ®Google Scholar
• Bianco A, Larosa E, Pileggi C, et al. Collaborative working group.appropriateness of intrapartum antibiotic prophylaxis to prevent neonatal group B streptococcus disease. PLoS One. 2016;11(11):e0166179.
   PubMed Web of Science ®Google Scholar
• El Helali N, Giovangrandi Y, Guyot K, et al. Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries. Obstet Gynecol. 2012;119(4):822–829.
   PubMed Web of Science ®Google Scholar
• Lin FY, Brenner RA, Johnson YR, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol. 2001;184(6):1204–1210.
   PubMed Web of Science ®Google Scholar
• Davis RL, Hasselquist MB, Cardenas V, et al. Introduction of the new centers for disease control and prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. Am J Obstet Gynecol. 2001;184(4):603–610.
   PubMed Web of Science ®Google Scholar
• Berardi A, Di Fazzio G, Gavioli S, et al. GBS prevention working group, Emilia-Romagna. Universal antenatal screening for group B streptococcus in Emilia-Romagna. J Med Screen. 2011;18(2):60–64.
   PubMed Web of Science ®Google Scholar
• Eastwood KA, Craig S, Sidhu H, et al. Prevention of early-onset Group B streptococcal disease – the Northern Ireland experience. BJOG. 2015;122(3):361–367.
   PubMed Web of Science ®Google Scholar
• Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol. 2013;121(3):570–577.
   PubMed Web of Science ®Google Scholar
• Goins WP, Talbot TR, Schaffner W, et al. Adherence to perinatal group B streptococcal prevention guidelines. Obstet Gynecol. 2010;115(6):1217–1224.
   PubMed Web of Science ®Google Scholar
• Turrentine MA, Greisinger AJ, Brown KS, et al. Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis. Infect Dis Obstet Gynecol. 2013;2013:525878.
   PubMedGoogle Scholar
• Eisenberg E, Craig AS, Gautam S, et al. Beyond screening: identifying new barriers to early onset group B streptococcal disease prevention. Pediatr Infect Dis J. 2005;24(6):520–524.
   PubMed Web of Science ®Google Scholar
• Barber EL, Funai EF, Bracken MB, et al. Interpretation of 2002 centers for disease control guidelines for group B streptococcus and evolving provider practice patterns. Am J Perinatol. 2011;28(2):97–102.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Dukhovny D, Mao W, et al. 2010 perinatal GBS prevention guideline and resource utilization. Pediatrics. 2014;133(2):196–203.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Taylor JA, Von Kohorn I, et al. Variation in sepsis evaluation across a national network of nurseries. Pediatrics. 2017;139(3):e20162845.
   PubMed Web of Science ®Google Scholar
• Tzialla C, Berardi A, Farina C, et al. Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies. Ital J Pediatr. 2017;43(1):98.
   PubMedGoogle Scholar
• Scasso S, Laufer J, Rodriguez G, et al. Vaginal group B streptococcus status during intrapartum antibiotic prophylaxis. Int J Gynaecol Obstet. 2015;129(1):9–12.
   PubMed Web of Science ®Google Scholar
• McNanley AR, Glantz JC, Hardy DJ, et al. The effect of intrapartum penicillin on vaginal group B streptococcus colony counts. Am J Obstet Gynecol. 2007;197(6):583.e1–4.
   PubMed Web of Science ®Google Scholar
• Berardi A, Rossi C, Biasini A, et al. Efficacy of intrapartum chemoprophylaxis less than 4 hours duration. J Matern Fetal Neonatal Med. 2011;24(4):619–625.
   PubMed Web of Science ®Google Scholar
• Hickman ME, Rench MA, Ferrieri P, et al. Changing epidemiology of group B streptococcal colonization. Pediatrics. 1999;104:203–209.
   PubMed Web of Science ®Google Scholar
• Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol. 2006;108(5):1254–1265.
   PubMed Web of Science ®Google Scholar
• De Cueto M, Sanchez MJ, Sampedro A, et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol. 1998;91(1):112–114.
   PubMed Web of Science ®Google Scholar
• Pylipow M, Gaddis M, Kinney JS. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics. 1994;93:31–35.
   Web of Science ®Google Scholar
• Boyer KM, Gadzala CA, Kelly PD, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis. 1983;148:810–816.
   PubMed Web of Science ®Google Scholar
• Lijoi D, Di Capua E, Ferrero S, et al. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. Arch Gynecol Obstet. 2007;275(5):373–379.
   PubMedGoogle Scholar
• Berardi A, Rossi C, Guidotti I, et al. Factors associated with intrapartum transmission of group B streptococcus. Pediatr Infect Dis J. 2014;33(12):1211–1215.
   PubMed Web of Science ®Google Scholar
• Bromberger P, Lawrence JM, Braun D, et al. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics. 2000;106:244–250.
   PubMed Web of Science ®Google Scholar
• Pinto NM, Soskolne EI, Pearlman MD, et al. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems. J Perinatol. 2003;23(4):265–271.
   PubMedGoogle Scholar
• Rosenstein NE, Schuchat A. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The neonatal group B streptococcal disease study group. Obstet Gynecol. 1997;90(6):901–906.
   PubMed Web of Science ®Google Scholar
• Berardi A, Spada C, Reggiani ML, et al. GBS prevention working group of Emilia-Romagna. Group B streptococcus early-onset disease and observation of well-appearing newborns. PLoS One. 2019;14(3):e0212784.
   PubMed Web of Science ®Google Scholar
• Berardi A, Lugli L, Rossi C, et al. GBS prevention working group, Emilia-Romagna. Impact of perinatal practices for early-onset group B Streptococcal disease prevention. Pediatr Infect Dis J. 2013;32(ì):e265–71.
   PubMedGoogle Scholar
• Cantey JB, Baird SD. Ending the culture of culture-negative sepsis in the. Neonatal ICU Pediatrics. 140(4):e20170044. 2017.
   PubMed Web of Science ®Google Scholar
• Berardi A, Spada C, Creti R, et al. Risk factors for group B streptococcus early-onset disease: an Italian, area-based, case-control study. J Matern Fetal Neonatal Med. 2019;17:1–7.
   Google Scholar
• Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115(5):1240–1246.
   PubMed Web of Science ®Google Scholar
• Velaphi S, Siegel JD, Wendel GD Jr, et al. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics. 2003;111(3):541–547.
   PubMed Web of Science ®Google Scholar
• Stafford IA, Stewart RD, Sheffield JS, et al. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease. Obstet Gynecol. 2012;120(1):123–129.
   PubMed Web of Science ®Google Scholar
• Viel-Theriault I, Fell DB, Grynspan D, et al. The transplacental passage of commonly used intrapartum antibiotics and its impact on the newborn management: A narrative review. Early Hum Dev. 2019;135:6–10.
   PubMed Web of Science ®Google Scholar
• Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet. 2004;43(8):487–514.
   PubMed Web of Science ®Google Scholar
• Griffiths SK, Campbell JP. Placental structure, function and drug transfer. Contin Educ Anaesth Crit Care Pain. 2015;15(2):84–89.
   Google Scholar
• Allegaert K, van Mieghem T, Verbesselt R, et al. Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol. 2008;200:170–171.
   PubMed Web of Science ®Google Scholar
• Lalic-Popovic M, Paunkovic J, Grujic Z, et al. Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes. J Diabetes. 2016;8:238–245.
   PubMed Web of Science ®Google Scholar
• Brown CE, Christmas JT, Bawdon RE. Placental transfer of cefazolin and piperacillin in pregnancies remote from term complicated by Rh isoimmunization. Am J Obstet Gynecol. 1990;163(3):938–943.
   PubMed Web of Science ®Google Scholar
• Groff SM, Fallatah W, Yang S, et al. Effect of maternal obesity on maternal-fetal transfer of preoperative cefazolin at cesarean section. J Pediatr Pharmacol Ther. 2017;22(3):227–232.
   PubMedGoogle Scholar
• Fiore Mitchell T, Pearlman MD, Chapman RL, et al. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol. 2001;98(6):1075–1079.
   PubMed Web of Science ®Google Scholar
• Bloom SL, Cox SM, Bawdon RE, et al. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol. 1996;175:974–976.
   PubMed Web of Science ®Google Scholar
• Colombo DF, Lew JL, Pedersen CA, et al. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of group B streptococcus. Am J Obstet Gynecol. 2006;194(2):466–470.
   PubMed Web of Science ®Google Scholar
• Barber EL, Zhao G, Buhimschi IA, et al. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol. 2008;112:265–270.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Colombo DF, Gardner D, et al. Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus. Am J Obstet Gynecol. 2001;185(4):850–853.
   PubMed Web of Science ®Google Scholar
• Berardi A, Pietrangiolillo Z, Bacchi Reggiani ML, et al. Are postnatal ampicillin levels actually related to the duration of intrapartum antibiotic prophylaxis prior to delivery? A pharmacokinetic study in 120 neonates. Arch Dis Child Fetal Neonatal Ed. 2018;103:F152–6.
   PubMed Web of Science ®Google Scholar
• Berardi A, Lugli L, Baronciani D, et al. GBS prevention working group of Emilia-Romagna. Group B streptococcal infections in a northern region of Italy. Pediatrics. 2007;120(3):e487–93.
   PubMed Web of Science ®Google Scholar
• Berardi A, Lugli L, Rossi C, et al. Intrapartum antibiotic prophylaxis failure and group-B streptococcus early-onset disease. J Matern Fetal Neonatal Med. 2011;24(10):1221–1224.
   PubMed Web of Science ®Google Scholar
• Tudela CM, Stewart RD, Roberts SW, et al. Intrapartum evidence of early-onset group B streptococcus. Obstet Gynecol. 2012;119(3):626–629.
   PubMed Web of Science ®Google Scholar
• Albers WH, Tyler CW, Boxerbaum B. Asymptomatic bacteremia in the newborn infant. J Pediatr. 1966;69:193.
   PubMed Web of Science ®Google Scholar
• Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–371.
   PubMed Web of Science ®Google Scholar
• Cantoni L, Ronfani L, Da Riol R, et al. Physical examination instead of laboratory tests for most infants born to mothers colonized with group B Streptococcus: support for the centers for disease control and prevention’s 2010 recommendations. J Pediatr. 2013;163:568–573.
   PubMed Web of Science ®Google Scholar
• Joshi NS, Gupta A, Allan JM, et al. Clinical monitoring of well-appearing infants born to mothers with chorioamnionitis. Pediatrics. 2018;141(4):e20172056.
   PubMed Web of Science ®Google Scholar